Trials / Completed
CompletedNCT03958253
Lung Cancer Screening Protocol
I-STEP: Increasing Screening Through Engaging Primary Care Providers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 193 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Toolbox for Lung Cancer Screening | -Toolbox of evidence-based elements that a primary care or referral site could implement to address known barriers to screening and referral, as well as required elements for screening. These elements will be designed to be adaptable to the unique needs and screening processes of the participating practices. * Patient education materials * Primary care practice educational materials * Pack-years/eligibility calculator * Local referral process guide * Smoking cessation materials and support * Shared decision-making guide * LDCT best practice guidelines |
Timeline
- Start date
- 2019-04-22
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
- First posted
- 2019-05-21
- Last updated
- 2021-04-08
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03958253. Inclusion in this directory is not an endorsement.